Skip to main content
MEDICLIN AG logo

MEDICLIN AG — Investor Relations & Filings

Ticker · MED ISIN · DE0006595101 LEI · 5299007ZHUSGAJRMWH73 F Human health and social work activities
Filings indexed 527 across all filing types
Latest filing 2023-09-21 Board/Management Inform…
Country DE Germany
Listing F MED

About MEDICLIN AG

https://www.mediclin.de/

MEDICLIN AG is an operator of healthcare facilities, providing medical services across a network of hospitals, rehabilitation clinics, nursing care homes, and outpatient medical centers. The company's core business is divided into three primary segments: acute care, post-acute care/rehabilitation, and nursing care. It offers specialized inpatient and outpatient treatment in numerous medical fields, including neurology, psychosomatics, orthopedics, internal medicine, cardiology, and oncology. MEDICLIN places a significant emphasis on rehabilitation, engaging in research and developing innovative therapeutic concepts. This includes specialized programs for conditions such as Post-COVID syndrome and a digital teletherapy platform, MEDICLIN HOME, for online rehabilitation.

Recent filings

Filing Released Lang Actions
MediClin AG: Thomas Piefke becomes a member of MEDICLIN's Management Board and will be responsible for the post-acute segment in the future
Board/Management Information Classification · 100% confidence The document is a news release announcing a change in senior management: Thomas Piefke is appointed to the Management Board, succeeding Dr. York Dhein. The key phrase is 'Thomas Piefke becomes a member of MEDICLIN’s Management Board'. This directly corresponds to the definition of Board/Management Information (MANG). The document is short and appears to be an official announcement rather than a comprehensive report.
2023-09-21 English
Half-yearly financial report 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report of MEDICLIN Aktiengesellschaft' and covers the period from 1 January 2023 to 30 June 2023. It contains detailed financial statements, key performance indicators, and a management report (Interim Group management report). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H2 2023
2023-08-01 English
MediClin AG: Higher demand for medical, therapeutic and nursing services led to an increase in sales and earnings in the Group
Earnings Release Classification · 100% confidence The document explicitly mentions 'Key word(s): Half Year Results' and provides financial figures for the 'first six months of the current financial year' (H1 2023 vs H1 2022). It concludes by stating, 'The interim report as of 30 June 2023 is available from today under www.mediclin.de...'. This structure—a summary announcement of half-year results followed by a reference to the full interim report—is characteristic of an Earnings Release (ER) or an announcement leading to an Interim Report (IR). Since the text contains detailed financial performance metrics (sales, operating result, patient numbers) and management commentary on the period, it functions as the initial release of period results. However, the definition for Interim / Quarterly Report (IR) is 'Comprehensive financial report for a period shorter than a year (e.g., half-year)'. Given the content is a summary of the half-year performance, it aligns best with the comprehensive nature of an IR, even though it is presented as a news release. If it were purely highlights, ER would be better, but this contains substantial detail. The final sentence confirms the existence of the full 'interim report'. Therefore, classifying it as the Interim Report (IR) is most appropriate, as it summarizes the required period's performance comprehensively. H1 2023
2023-07-31 English
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2023 bis zum 30.06.2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for MEDICLIN Aktiengesellschaft covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial statements, key performance indicators (KPIs), a management report (Konzernzwischenlagebericht), and analysis of the financial and asset position. Since it is a comprehensive financial report for a period shorter than a full fiscal year and contains substantive financial data, it is classified as an Interim/Quarterly Report. H1 2023
2023-07-31 German
Halbjahresfinanzbericht 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenbericht' (Interim Report) for MEDICLIN Aktiengesellschaft covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial statements, key performance indicators (KPIs), a management discussion and analysis (Konzernzwischenlagebericht), and segment reporting. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-07-31 German
MediClin AG: MEDICLIN focusses on innovative outpatient concepts in rehabilitation
AGM Information Classification · 99% confidence The document explicitly mentions 'General Annual Meeting of MEDICLIN Aktiengesellschaft' and details the voting results on the actions of the Management Board and Supervisory Board, as well as the approval of the remuneration report, all occurring at the AGM. The keyword 'AGM/EGM' is present in the metadata section. This content strongly aligns with the description of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2023-06-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.